ISG20
Interferon-stimulated gene 20 kDa protein
Also known as: CD25, HEM45, ISG20_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96AZ6
- Gene
- ISG20
- Ensembl
- ENSG00000172183
- Chromosome
- 15
- Canonical length
- 181 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
Enables 3'-5' exonuclease activity and RNA binding activity. Involved in defense response to virus; negative regulation of viral genome replication; and nucleobase-containing compound catabolic process. Located in cytoplasm and nuclear lumen. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
181 residues, UniProt reviewed canonical sequence.
>Q96AZ6|ISG20
1 MAGSREVVAM DCEMVGLGPH RESGLARCSL VNVHGAVLYD KFIRPEGEIT DYRTRVSGVT
61 PQHMVGATPF AVARLEILQL LKGKLVVGHD LKHDFQALKE DMSGYTIYDT STDRLLWREA
121 KLDHCRRVSL RVLSERLLHK SIQNSLLGHS SVEDARATME LYQISQRIRA RRGLPRLAVS
181 DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ISG20 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 177 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 177 nTPM
- spleen: 140 nTPM
- thymus: 81 nTPM
- appendix: 74 nTPM
- duodenum: 73 nTPM
- stomach: 65 nTPM
Single-cell type
- plasma cells: 1,105 nCPM
- esophageal apical cells: 725 nCPM
- endometrial ciliated cells: 323 nCPM
- b-cells: 321 nCPM
- t-cells: 318 nCPM
- nk-cells: 306 nCPM
Immune cell
- neutrophil: 1,347 nTPM
- T-reg: 1,248 nTPM
- naive B-cell: 1,191 nTPM
- memory B-cell: 1,155 nTPM
- memory CD4 T-cell: 511 nTPM
- memory CD8 T-cell: 433 nTPM
Brain region
- cerebral cortex: 15 nTPM
- medulla oblongata: 13 nTPM
- thalamus: 11 nTPM
- white matter: 10 nTPM
- basal ganglia: 9.6 nTPM
- pons: 8.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.69
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.21
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- defense response to virus
- DNA catabolic process
- innate immune response
- negative regulation of viral genome replication
- response to virus
- RNA catabolic process
- RNA processing
- rRNA processing
Molecular functions
- 3'-5'-RNA exonuclease activity
- exonuclease activity
- exoribonuclease II activity
- metal ion binding
- single-stranded DNA 3'-5' DNA exonuclease activity
- U1 snRNA binding
- U2 snRNA binding
- U3 snoRNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ISG20 as an antibody target. Whether an autoantibody or antibody against ISG20 could matter depends on whether native ISG20 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ISG20 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ISG20 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...